Cargando…
Complement Therapeutics in the Multi-Organ Donor: Do or Don't?
Over the last decade, striking progress has been made in the field of organ transplantation, such as better surgical expertise and preservation techniques. Therefore, organ transplantation is nowadays considered a successful treatment in end-stage diseases of various organs, e.g. the kidney, liver,...
Autores principales: | van Zanden, Judith E., Jager, Neeltina M., Daha, Mohamed R., Erasmus, Michiel E., Leuvenink, Henri G. D., Seelen, Marc A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400964/ https://www.ncbi.nlm.nih.gov/pubmed/30873176 http://dx.doi.org/10.3389/fimmu.2019.00329 |
Ejemplares similares
-
Brain death‐induced lung injury is complement dependent, with a primary role for the classical/lectin pathway
por: van Zanden, Judith E., et al.
Publicado: (2020) -
Blocking Complement Factor B Activation Reduces Renal Injury and Inflammation in a Rat Brain Death Model
por: Jager, Neeltina M., et al.
Publicado: (2019) -
Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys
por: Jager, Neeltina M., et al.
Publicado: (2022) -
The do’s, don’t and don’t knows of supporting transition to more independent practice
por: Yardley, Sarah, et al.
Publicado: (2018) -
Don't do the Bosenova
Publicado: (2008)